Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Paul L Swiecicki
SWOG Cancer Research Network
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Uc San Diego Moores Cancer Center
La Jolla, California, United States
- Yale University
New Haven, Connecticut, United States
- Smilow Cancer Hospital Care Center-Trumbull
Trumbull, Connecticut, United States
- Smilow Cancer Hospital Care Center - Waterford
Waterford, Connecticut, United States
- Carle at the Riverfront
Danville, Illinois, United States
- Carle Physician Group-Effingham
Effingham, Illinois, United States
- Carle Physician Group-Mattoon/charleston
Mattoon, Illinois, United States
- Carle Bromenn Medical Center
Normal, Illinois, United States
- Carle Cancer Institute Normal
Normal, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, United States
- Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth
Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen
Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack
Commack, New York, United States
- Memorial Sloan Kettering Westchester
Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Memorial Sloan Kettering Nassau
Uniondale, New York, United States
- Uh Seidman Cancer Center at Uh Avon Health Center
Avon, Ohio, United States
- Uhhs-Chagrin Highlands Medical Center
Beachwood, Ohio, United States
- University of Cincinnati Cancer Center-Uc Medical Center
Cincinnati, Ohio, United States
- Case Western Reserve University
Cleveland, Ohio, United States
- University of Cincinnati Cancer Center-West Chester
West Chester, Ohio, United States
- University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
- Ut Md Anderson Cancer Center
Houston, Texas, United States
- Froedtert Menomonee Falls Hospital
Menomonee Falls, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
- Froedtert and Mcw Moorland Reserve Health Center
New Berlin, Wisconsin, United States
- Drexel Town Square Health Center
Oak Creek, Wisconsin, United States
- Froedtert West Bend Hospital/kraemer Cancer Center
West Bend, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Mar 2026
- Primary completion
- 28 Feb 2029
- Completion
- 28 Feb 2029
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 86
- Registry id
- NCT07042295
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.